Compare

Cingulate Inc. vs Cellectar Biosciences, Inc. vs Reviva Pharmaceuticals Holdings, Inc. vs Biovie Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Cingulate Inc. CING	Cellectar Biosciences, Inc. CLRB	Reviva Pharmaceuticals Holdings, Inc. RVPH	Biovie Inc. BIVI
Year ended	2025-12-31	2025-12-31	2025-12-31	2026-06-30
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$22.45M	-$21.79M	-$19.86M	-$22.07M
EPS (Diluted)	-$4.44	-$8.35	n/a	-$3.05
Operating cash flow	-$17.25M	-$23.12M	-$24.59M	-$19.02M
Free cash flow	-$17.41M	-$23.12M	n/a	n/a
Cash & equivalents	$10.95M	$13.20M	$14.44M	$8.98M
Total assets	$15.07M	$14.98M	$15.92M	$14.25M
Total liabilities	$12.56M	$5.06M	$7.28M	$3.98M
Shareholders' equity	$2.51M	$8.54M	$8.65M	$10.27M
Return on year-end equity	-894.8%	-255.2%	-229.7%	-214.9%
Shares outstanding	7.25M	4.24M	5.87M	7.54M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Cingulate Inc.	Cellectar Biosciences, Inc.	Reviva Pharmaceuticals Holdings, Inc.	Biovie Inc.
Latest	n/a	n/a	n/a	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a